Cutaneous manifestations of Epstein-Barr virus infection

Dermatologic Clinics

Volumn 20, Issue 2, 2002, Pages 283-289

  Ikediobi, Nneka I ^a,c   Tyring, Stephen K ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIFUNGAL AGENT; CORTICOSTEROID; HETEROPHILE ANTIBODY; PODOPHYLLIN; RETINOID; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; ARM; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EPSTEIN BARR VIRUS; HUMAN; IMMUNE STATUS; INFECTIOUS MONONUCLEOSIS; LEUKOPLAKIA; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RASH; REVIEW; SKIN LYMPHOMA; TRUNK; VIRUS INFECTION; VIRAL SKIN DISEASE;

EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMAN; SKIN DISEASES, VIRAL; HUMANS;

EID: 0035986480     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(01)00014-6     Document Type: Review

References (71)

1. Virus particles in cultured lymphoblasts from Burkitt's lymphoma
2. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis
3. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx
4. Epstein-Barr virus infection
5. Role of epithelium in EBV persistence and pathogenesis of B-cell tumours
6. Epstein-Barr virus replication in oropharyngeal epithelial cells
7. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: Implications for the interindividual infection route of Epstein-Barr virus
8. Epstein-Barr virus (EBV) infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells
9. Epstein-Barr virus infection
10. Infectious mononucleosis
11. Cutaneous manifestations of infectious mononucleosis
12. Eruptions from ampicillin in patients with infectious mononucleosis
13. Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis
14. Amoxycillin rash in infectious mononucleosis
15. Methicillin rash in infectious mononucleosis
16. Drug eruption induced by acetaminophen in infectious mononucleosis
17. Cephalexin rash in infectious mononucleosis
18. Quinolone drug rash in a patient with infectious mononucleosis
19. Erythromycin rash in glandular fever
20. Circulating immune complexes and complement sequence activation in infectious mononucleosis
21. Temporary skin reactions to penicillins during the acute stage of infectious mononucleosis
22. Ampicillin sensitivity in infectious mononucleosis: Temporary or permanent?
23. Infectious mononucleosis presenting as urticaria
24. Acute urticaria in infectious mononucleosis
25. Cold urticaria associated with infectious mononucleosis
26. Cold urticaria in infectious mononucleosis
27. Immune complex disease associated with Epstein-Barr virus infectious mononucleosis
28. Erythema nodosum associated with infectious mononucleosis
29. Eruptive acne vulgaris with infectious mononucleosis
30. Recovery of Epstein-Barr virus from genital ulcers
31. Genital ulcers and mononucleosis
32. Oral hairy leukoplakia: A manifestation of primary infection with Epstein-Barr virus?
33. Molecular diagnosis of Epstein-Barr virus-related diseases
34. Acyclovir for treatment of infectious mononucleosis: A meta-analysis
35. Acyclovir and prednisolone treatment of acute infectious mononucleosis: A multicenter, double-blind, placebo-controlled study
36. Successful treatment of Epstein-Barr virus infection associated with myocarditis
37. Infectious mononucleosis and bilateral peritonsillar abscesses resulting in airway obstruction
38. Peritonsillar abscess and infectious mononucleosis: An association or a different presentation of the same condition
39. Oral "hairy" leucoplakia in male homosexuals: Evidence of association with both papillomavirus and a herpes-group virus
40. Oral hairy leukoplakia in a patient with multiple myeloma
41. Hairy leukoplakia in an HIV-seronegative patient
42. Oral hairy leukoplakia in nonimmunosuppressed patients: Report of four cases
43. Oral hairy leukoplakia in an HIV-negative woman with Behcet's syndrome
44. Oral hairy leukoplakia: Clinicopathologic features, pathogenesis, diagnosis, and clinical significance
45. Viral lesions of the mouth in HIV-infected patients
46. Demonstration of Epstein-Barr virus DNA and human papillomavirus DNA in acetowhite lesions of the penile skin and the oral mucosa
47. Hairy leukoplakia: An unusual combination of transforming and permissive Epstein-Barr virus infections
48. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia
49. Epstein-Barr virus infection in oral hairy leukoplakia: Virus replication in the absence of a detectable latent phase
50. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia
51. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia
52. Epstein-Barr virus reactivation in hairy leukoplakia
53. Detection of Epstein-Barr virus in oral scrapes in HIV infection, in hairy leukoplakia, and in healthy non-HIV-infected people
54. Exfoliative cytology and electron microscopy in the diagnosis of hairy leukoplakia
55. Regression of oral hairy leukoplakia after oral administration of acyclovir
56. Treatment of HIV-related hairy leukoplakia with podophyllum resin 25% solution
57. Efficacy of desciclovir in the treatment of Epstein-Barr virus infection in oral hairy leukoplakia
58. Resolution of oral hairy leukoplakia during therapy with 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG)
59. Treatment of oral "hairy" leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically)
60. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma
61. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations
62. Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and Sezary syndrome
63. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: A study of 64 patients
64. Primary cutaneous T-cell lymphoma with an angiocentric growth pattern: Association with Epstein-Barr virus
65. Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides
66. Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and pseudolymphomas
67. Cutaneous angiocentric T-cell lymphoma associated with Epstein-Barr virus
68. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face
69. Epstein-Barr virus-associated lymphoproliferative skin lesion with recurrent necrotic papulovesicles of the face
70. Posttransplant cutaneous lymphoma